Fig. 13.1
(a) The pump is exposed through an extended left subcostal incision . A self-retaining retractor is invaluable in visualizing the white silicone rubber bellows that surrounds the pump inlet graft. (b) The bend-relief is disconnected from the pump outlet so that the outflow graft can be exposed. After hemodynamic stability is ensured, the pump power is turned off, and the driveline is cut. (c) Clamps are immediately placed on the outlet graft and the silicone rubber inflow bellows to prevent retrograde flow through the nonfunctioning pump. (d) The outflow graft is unscrewed from the curved titanium tube at the pump outlet. Brisk backflow is confirmed by transiently releasing the clamp to ensure adequacy of the outflow graft. (e) A pump clamp is used to firmly grasp the collar at the pump inlet. (f) While the collar is held, the pump is rotated counterclockwise until it can be removed from the inlet. Brisk bleeding from the inlet is confirmed by transiently releasing the clamp on the inflow bellows to ensure adequacy of the pump inflow. The new pump is implanted by performing these steps in the reverse order
Next, additional dissection is done around the inflow cannula to allow a vascular clamp to be applied across the white silicone elastic bellows between the sintered titanium inflow cannula and the pump. When the vascular clamp is placed, the bellows and graft are compressed to temporarily occlude inflow (Fig. 13.1c). The old driveline is dissected circumferentially for several centimeters so that the driveline can be easily transected before the pump is removed.
Heparin is administered systemically, and pump speed is gradually decreased to slowly wean the patient from the HeartMate II . Transesophageal echocardiography is used to determine whether hemodynamic stability can be maintained for 10–15 min without CF-LVAD support. Inotropes and vasoactive agents are used as needed. Patients with extremely poor LV function may require CPB.